5 Year Check-In: What’s Changed in Eating Disorder Treatment?
Over the last five years, the field of eating disorder (ED) treatment has grown in understanding, sophistication, and accessibility. As someone on the front lines of this work, I’ve witnessed meaningful shifts in how we think about recovery, whom we serve, and how we deliver care. In this post I’ll share the highlights — not polished academic summaries, but what I’ve actually seen change.
1. A Move Toward Neurodiversity-Affirming Care
More practitioners now recognize that many people with eating disorders are also neurodivergent (e.g., autistic, ADHD). What this has meant in practice:
Treatment plans are adjusted for sensory needs, executive functioning differences, and social processing.
Strategies honour why behaviours happen (e.g., sensory regulation) instead of just what they look like.
Therapists are learning to reduce “one-size-fits-all” expectations.
This shift hasn’t happened everywhere, but it’s growing — and it makes treatment far more respectful and effective for many people.
2. Trauma-Informed Approaches Are Becoming Standard
Eating disorders are often connected to difficult life experiences. In the last five years, clinicians have increasingly woven trauma-informed care into every level of treatment by:
Recognizing symptoms as coping mechanisms rather than moral failures.
Prioritizing safety, consent, and bodily autonomy in therapy.
Using somatic and relational interventions alongside cognitive work.
This perspective changes the tone of treatment — from punitive to compassionate — and that makes a profound difference in engagement and outcomes.
3. Medications and Brain-Based Support Have Expanded
While there’s no “pill that cures” an eating disorder, recent research has broadened our pharmacological tools— both positively & negatively, especially for:
Binge-eating disorder (BED) — with FDA-approved options like lisdexamfetamine (Vyvanse)
Addressing co-occurring conditions such as anxiety, depression, or OCD.
An increase in weight loss medications (GLP-1) being more accessible/lower barrier screening
What’s important isn’t just which meds are available, but that medication is now more often seen as one piece of a multimodal, individualized plan rather than an afterthought. Alternatively, with the more common use of GLP-1’s, we are also seeing an increase in disordered eating behaviours, or misuse by those with existing eating disorders.
4. Broader Views of Recovery — Beyond Weight
Five years ago, recovery metrics often focused heavily on weight benchmarks. Now, many teams emphasize:
Functioning (how someone lives and engages in life),
Quality of life,
Relationships with food and self, and
Psychological flexibility.
Clinicians are more cautious about equating weight with health, especially for people whose bodies don’t fit narrow medical norms.
5. Equity, Diversity & Inclusion Are (Finally) Being Taken Seriously
The stereotype of the “white, affluent teenage girl” with an eating disorder is outdated. In the last half-decade, clinicians have:
Acknowledged the prevalence of EDs in BIPOC, LGBTQ+, and male populations.
Adapted screening tools and language to be culturally sensitive.
Challenged biases that delay diagnosis and treatment access.
There’s still so much work to do, but the conversation has shifted meaningfully.
What This Means for You
If you’re someone navigating recovery — or supporting someone who is — here’s the good news:
Treatment today is more personalized, more compassionate, and more flexible than ever before.
Your lived experience matters in shaping your care.
There are more tools and more paths to recovery — and you don’t have to follow a single, rigid route.